Parkinson’s Disease Resources
Web Content:
- In Vitro Assays for Parkinson’s Disease
- Parkinson’s Disease Studies: Induced & Transgenic Models
- Imaging
- Fine Motor Kinematic Analysis
Articles and Content:
- End to End Drug Discovery Capabilities for Parkinson’s Disease poster
- Poster Presentation Video: a-Synuclein Aggregation Assay for Parkinson’s Disease
- Selective, Brain-Penetrant Small Molecule Inhibitors of LRRK2: A Discovery Story
Webinars:
- A Comprehensive Review of Biomarker Endpoints in In Vivo Models of Parkinson’s Disease
- In Vitro Phenotypic Assays as Predictive Tools to Drive Parkinson’s Disease Drug Discovery
- Phenotypic Assays to Advance Novel Neurological Disease Drug Discovery
- Using Fine Motor Kinematic and Gait Analysis in In Vivo Pharmacology Studies
- The Search for Clinically Relevant Motor Behaviors in Animal Models of Parkinson's Disease
Scientific Posters:
- Administration of AAV Alpha-synuclein to C57BL6/J and G2019s Mice
- Administration of AAV Alpha-synuclein in SD and G2019S-LRRK2 Rats
- Assay Development and Validation of a High Content-based High-throughput Assay to Measure α-Synuclein Aggregation in Dopaminergic Human Neurons Differentiated In Vitro
- Assessment of Haloperidol-induced Tremulous Jaw Movement in Rats Using Loose Restraint and a Video Recording System
- Behavioral Consequences of Administration of AAV Alpha-synuclein to Rat
- Characterization of Alpha-synuclein and Neurotransmitters During the Sleep Wake Cycle of a Parkinson’s Disease Model Expressing Human Wild-Type Alpha-Synuclein
- Imaging of Dopamine Transporter in Rodents Using PET and SPECT